Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta-analysis.

Se Hee MinJeong-Hwa YoonSeokyung HahnYoung Min Cho

Published in: Journal of diabetes investigation (2017)

The addition of a DPP4 inhibitor to patients with type 2 diabetes inadequately controlled with an AGI achieved better glycemic control without further increasing the risk of weight gain and hypoglycemia.

Keyphrases

glycemic control
weight gain
combination therapy
type diabetes
body mass index
weight loss
birth weight
blood glucose
molecular docking
insulin resistance
adipose tissue
skeletal muscle